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blinded, randomized, superiority clinical trial
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Abstract
Background: Depression is estimated to become the leading cause of disease burden globally by 2030. Despite
existing efficacious treatments (both medical and psychotherapeutic), a large proportion of patients do not respond
to therapy. Recent insights from evolutionary psychology suggest that, in addition to targeting the proximal causes
of depression (for example, targeting dysfunctional beliefs by cognitive behavioral therapy), the distal or
evolutionary causes (for example, inclusive fitness) should also be addressed. A randomized superiority trial is
conducted to develop and test an evolutionary-driven cognitive therapy protocol for depression, and to compare
its efficacy against standard cognitive therapy for depression.
Methods/design: Romanian-speaking adults (18 years or older) with elevated Beck Depression Inventory (BDI)
scores (>13), current diagnosis of major depressive disorder or major depressive episode (MDD or MDE), and MDD
with comorbid dysthymia, as evaluated by the Structured Clinical Interview for DSM-IV (SCID), are included in the
study. Participants are randomized to one of two conditions: 1) evolutionary-driven cognitive therapy (ED-CT) or 2)
cognitive therapy (CT). Both groups undergo 12 psychotherapy sessions, and data are collected at baseline,
mid-treatment, post-treatment, and the 3-month follow-up. Primary outcomes are depressive symptomatology and
a categorical diagnosis of depression post-treatment.
Discussion: This randomized trial compares the newly proposed ED-CT with a classic CT protocol for depression.
To our knowledge, this is the first attempt to integrate insights from evolutionary theories of depression into the
treatment of this condition in a controlled manner. This study can thus add substantially to the body of knowledge
on validated treatments for depression.
Trial registration: Current Controlled Trials ISRCTN64664414
The trial was registered in June 2013. The first participant was enrolled on October 3, 2012.
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Background
Depression affects around 350 million people worldwide,
and is estimated to become the leading cause of disease
burden globally by 2030 [1]. More than 30 million people
are affected by depression in Europe alone, and the associ-
ated annual costs are estimated at €92 billion [2].
There are several existing effective treatments for depres-
sion, including cognitive behavioral therapy (CBT) [3-5],
interpersonal therapy (IPT) [6-10] and antidepressants [11].
CBT is the psychological standard of care for depression
recommended as the first-line psychotherapeutic interven-
tion [12]. In CBT, the root of the depressive symptoms is
seen as a set of dysfunctional core beliefs/schemas, which
distort information processing, thus leading to systematic
negative cognitive biases [3-5]. In CBT, the therapist tries
to modify these dysfunctional beliefs, as well as engage the
patient in rewarding activities.
IPT for depression focuses on ameliorating interpersonal
difficulties and emphasizes the role of social support in
the onset and maintenance of depression. The treatment
rationale in IPT is that improvement in interpersonal
relationships leads to improvement in depressive symp-
toms, which positively feeds back onto interpersonal
functioning [13]. Like CBT, IPT is one of the recom-
mended treatments of choice by the National Institute
for Clinical Excellence [12] and the National Institute
of Mental Health [14].
Research on the efficacy of the therapies for depression
shows that 30% to 50% of the patients do not respond to
anti-depressive medication [11], and around 40% of patients
with moderate to severe depression do not respond well to
CBT [15]. Moreover, 40% of those patients whose depres-
sion does remit will relapse within 2 years [16] and 20%
are at risk of developing chronic, unremitting depression
[16,17]. Generally, meta-analyses indicate that all bona fide
(non-placebo) psychological treatments for depression are
equally efficacious [18], and the effect sizes of psychother-
apy for adult depression vary from small to moderate [19].
Therefore, despite existing efficacious treatments, ef-
forts should be made to develop and provide improved
evidence-based treatment protocols for patients with
depression. These efforts should build on the already
validated treatment approaches and strive to add incre-
mental benefits by targeting additional factors potentially
involved in the onset or maintenance of depression. The
current clinical trial is designed to contribute to this de-
sired outcome.
Framework and rationale of the present study
Human behavior generally revolves around a finite set
of biosocially relevant themes, and focuses on fitness
maximization (that is, reproductive success). Biosocial
goals are behaviors that increase fitness or that historically
have increased fitness. Examples of these are satisfactory
outcomes in areas such as shelter and security, nutrition
and food acquisition, health, sexuality, mate selection,
attraction, protection and retention, parenting, and in-
group and between-group interactions [20]. Evolutionary
psychologists have noted that when humans are successful
at meeting these fitness-enhancing goals, they generally ex-
perience well-being and happiness [21]. On the other hand,
failure (perceived or real) to meet these challenges results
in dissatisfaction, depression, tension, or frustration [21].
A growing number of researchers are proposing that,
in addition to targeting proximal or immediate causes of
depression (for example, dysfunctional beliefs, as targeted
by CBT), barriers to fitness should also be addressed.
These factors are thought to be distal or evolutionary
causes of depression.
In one of the early attempts at evolutionary explanations
for depression, Dobson and Show [22] argued that Beck’s
cognitive distortions are a consequence of depression,
rather than a cause of it. Recent research has provided
more empirical support for these insights, which link
threats to fitness to depression. For example, a large
study conducted on a sample of 1,400 disaster workers
found that a successful slow fitness strategy (High-K)
was a negative predictor of a variety of psychopathologies,
including post-traumatic stress disorder, functional
disability, anger, and sleep disturbances [23]. Another
study showed that the same fitness strategy was an im-
portant negative predictor of depressive symptomatol-
ogy, accounting for 15% of the variance in scores on
the Beck Depression Inventory, Second Edition (BDI-II),
[24] after controlling for risk factors for depression [25].
Elsewhere, greater depressive symptomatology scores have
been shown to correlate negatively with ratings of mate
value for self, and indirectly predicted lower ratings of
mate value for short-term and long-term partners, as
well as best friends [26].
These findings support a relationship between fitness
level and depressive symptomatology, and suggest that
interventions that specifically target increasing fitness
could potentially alleviate depression.
Objectives
It is the goal of the present study to explore the efficacy of
formally incorporating interventions on the distal causes
of depression in the treatment of this condition. An
evolutionary-driven cognitive therapy (ED-CT) protocol
for depression is being developed and tested in this clinical
trial. Thus, patients with depression initially complete
a questionnaire aiming at identifying deficient areas of fit-
ness, and are guided by the therapist on ways of improving
on those areas. The therapeutic outcome will be compared
with the outcome of a group of patients with depression
undergoing a well-established CBT treatment, namely,
Beck’s cognitive therapy (CT) for depression [27].
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Trial design
This study is designed to be a blinded, randomized, super-
iority clinical trial. The experimental group receives ED-CT,
while the control group receives CT. We hypothesize that,
because the intervention array is larger in the case of ED-
CT, the therapeutic gains will be larger in this condition
than in the CT group at the completion of the therapy, and
that this will be maintained at the 3-month follow-up.
Methods
Study setting
The study population consists of Romanian adults with a
diagnosis of major depression as defined in the Diagnostic
and Statistical Manual of Mental Disorders, Fourth
Edition, Revised Text (DSM-IV-TR) [28], or with depres-
sive symptomatology. The study is being implemented
through the Babes-Bolyai University Psychological Clinic,
Cluj-Napoca, Romania.
Eligibility criteria
Romanian-speaking adults (18 years or older) with raised
BDI [24,29]) scores (>13), current diagnosis of major depres-
sive disorder or major depressive episode (MDD or MDE),
and MDD with comorbid dysthymia, are included in the
study. Participants presenting with panic disorder, sub-
stance abuse, psychotic symptoms, organic brain disorders
(for example, dementia), imminent risk of suicide, self-
injury or harming others, or serious legal or health issues
that would prevent from regularly attending, are excluded.
Interventions
The CT group
The CT group undergoes a 1-hour session of CT [27] each
week for 12 weeks. CT is a structured, goals-oriented,
short-term intervention organized around the concepts of
automatic thoughts and schema/core beliefs. A distinctive
feature of CT is the cognitive conceptualization of the
client’s problems. Problematic behaviors are seen as
consequences of the dysfunctional thinking patterns.
Therefore, clients are trained to identify and modify
dysfunctional automatic thoughts and beliefs. When
behavioral techniques are used, they are employed in
the service of cognitive change (for example, behavioral
experiments to challenge dysfunctional thoughts), as well
as to increase the number of positive reinforcements.
The treatment begins with the identification of negative
automatic thoughts (conceptualized as the most easily
accessible cognitive contents, as they are linked to specific
activating events), followed by the examination of their
validity and utility, to construct a more adaptive viewpoint
and thus decrease depressive symptoms. As the therapy
progresses, deeper cognitive structures are targeted
(including underlying assumptions/intermediate beliefs
and dysfunctional schemas), with the ultimate goal of
helping the client to achieve a remission of their depression
and prevent relapse.
The ED-CT group
The ED-CT group also undergoes a 1-hour session of ther-
apy each week for 12 weeks. Therapy sessions follow the
guidelines of the ED-CT manual that we have developed.
Following implementation of the study, the manual will
be available upon request from the first author, and will
also be submitted for publication.
The ED-CT starts with the administration of a Fitness
Evaluation Scale (FES), described below, which yields a
comprehensive assessment of the client’s perceived dar-
winian or evolutionary fitness. The therapist thus begins
the treatment with a clear understanding of the barriers to
fitness that the patient is facing, in addition to the prob-
lems formulated by them at the beginning of therapy. In
other words, the patient’s answers to the FES guide the
evolutionary-driven intervention elements by providing
additional focuses for treatment, alongside classic CT tar-
gets of intervention. Thus, the key difference between ED-
CT and a classic CT approach is that in the ED therapy,
the therapist comes pre-equipped with a list of fitness
deficiencies identified by the patient through the com-
pletion of the FES at intake, which the therapist ad-
dresses alongside other problems.
The ED-CT intervention is based on standard CT while
adding specific goals and techniques designed to increase
an individual’s evolutionary fitness. We will succinctly
describe the treatment course, focusing on the evolu-
tionary aspects of the treatment.
The first treatment session focuses on educating the
patient about typical topics such as depression and psy-
chotherapy, emphasizing the importance of ‘homework’
(personal practice of the therapy at home), taking respon-
sibility for change, and adjusting the patient’s expectations.
This session also focuses on presenting details about
specific ED-CT insights such as the mismatch theory
(the theory that cognitive structures which were adaptive
in a Pleistocene environment, but are now ‘mismatched’
to the current environment, lead to dysfunctional emotions
and behaviors), and about the hypothesized evolutionary
functions of depression [30]. The patient is informed in this
session about the research linking depression and fitness-
related behaviors, and why an evolutionary approach can
be suited as a guiding add-on to a CT intervention. This is
also the point at which the therapist discusses the problems
identified by the FES at intake, and, with the help of the pa-
tient, sets realistic goals to address them in future sessions.
The homework in this session usually consists of building
specific goals, using the FES as a guideline and as an ex-
ample of specific target behaviors.
Session 2 focuses on continuing to build the therapeutic
alliance and elaborating on the fitness problems list yielded
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by the FES. This session also provides the opportunity to
discuss with the patient their understanding of the distal
evolutionary causes of depression.
Sessions 3 to 6 focus on working on each of the fitness
deficiencies identified at intake. These problems are
conceptualized using evolutionary insights. For instance,
some dysfunctional beliefs and their consequences can
be seen as adaptive mental structures left over from the
Environment of Evolutionary Adaptedness (EEA) [31].
This helps the patient to experience control and self-
acceptance of their depressive symptoms. For example, a
patient can present guilt – a depression symptom – about
feelings or expressions of anger, fueled by beliefs such as:
‘I’m a horrible person because I got angry and yelled at
my neighbor.’ In this case, guilt is typically seen as a
secondary emotional problem (dysfunctional emotion
about other emotions) [32]. Evolutionary explanations
of anger (for example, anger as an adaptive reaction
during the EEA) can lower self-criticism and promote
self-acceptance by reducing the intensity of the sec-
ondary emotion (guilt in this example), thus enabling
the psychotherapist to work on the primary, present
problem (anger in this example).
Homework is negotiated during these sessions, and
generally consists of self-monitoring of emotions and
behaviors, cognitive restructuring, and behavioral acti-
vation tasks generated from the FES. Specific behaviors
that the patient does not engage in as captured by the FES
(for example, spending time in nature, healthy eating habits)
are targeted for activation. In addition, problem-solving,
conflict resolution, and assertiveness training are used
to enhance relationships with the patient’s relatives where
appropriate, thus tapping into indirect fitness, while direct
fitness (for example, mate value, health, income) is en-
hanced with standard CT techniques.
Sessions 7 to 10 are targeted at making headway towards
the resolution of some or all of the problems previously
identified by the FES, working toward strengthening the
patient’s adaptive beliefs and weakening the maladaptive
beliefs, and encouraging them to see the links between
problems, particularly those that are characterized by com-
mon dysfunctional beliefs. Core beliefs are identified and
approached in this part of the therapy. Standard CT tech-
niques are used to change beliefs and behaviors, but the
therapist often refers back to the evolutionary-informed CT
conceptualization. Homework continues to focus on FES-
generated behavioral activation, rehearsing adaptive state-
ments in real-life situations, and applying the techniques
and conceptualization to novel, diverse problems.
Sessions 11 and 12 prepare the patient for the task of
becoming their own future therapists, and for discussing
relapse prevention. The homework focuses on strengthen-
ing confidence in healthy core beliefs and promoting self-
acceptance and other-acceptance. Self-control techniques
in difficult situations are practiced, and solutions for pos-
sible relapses are tested before the end of the therapy.
Outcomes and measures
Primary outcomes
The level of depressive symptomatology and a categorical
diagnosis of depression after treatment constitute the
primary outcomes.
Secondary outcomes
Perceptions about quality of life and social functioning
constitute the secondary outcomes.
Because the interventions in the experimental group
target both proximal and distal causes of depression, it
is expected that they will lead to a greater decrease in
depressive symptomatology and a greater increase in qual-
ity of life and in social and occupational functioning than
those in the control group.
Other outcomes
We considered three sets of additional outcomes, as follows.
The first set comprises measures related to fitness and
mate value; self-reported physical health; behavioral activa-
tion; self-reported religiosity; self-reported coping strategies;
and measures of positive and negative emotions. We
decided to include these measures to investigate, in an
exploratory manner, if the eventual superiority of the
ED-CT intervention is related to improvements in fitness
dimensions (for example, kinship relations, upward mobility,
physical health, social capital) We also included behavioral
activation as a potential predictor of outcomes for both in-
terventions [27,33]. In addition, we were interested to see if
the ED-CT intervention efficacy is associated with a person’s
religiosity, as a high level of religious faith might undermine
the acceptance of the ED-CT intervention rationale. Lastly,
we included measures of emotionality and coping strategies
to explore the extent to which the newly devised interven-
tion might have broader clinical implications.
The second set of additional outcomes includes measures
of presumed mechanisms of change within classic CBT
(including CT): negative automatic thoughts [3], dysfunc-
tional attitudes [3,34], and irrational beliefs [35,36]. We
included these measures to examine, in an exploratory
manner, if the two interventions have differential effects
on the same cognitive mechanisms.
The third set of additional outcomes includes mea-
sures of working alliance, treatment outcome expectan-
cies, and client satisfaction with the therapy. We added
these measures to allow exploratory investigation of
the eventual differences between the two interventions
in terms of non-specific factors associated with the
treatment outcome.
The instruments that we use for measuring each of these
outcomes are briefly described below.
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Measures of primary outcomes
The Structured Clinical Interview for DSM-IV (SCID) [37],
specifically, the Overview, Mood Episodes, and Anxiety
Disorders modules, is used for the clinical assessment of
depression. The Overview module collects information
about sociodemographic variables (date of birth, marital
status, number of children, level of education, employment
status), drug use, physical and psychological treatment
history (including any past or current treatments for
depression), and current social functioning. The Mood
Episodes and Anxiety Disorders modules follow the diag-
nostic criteria of the DSM-IV-TR [28] for mood episodes
and anxiety disorders. The SCID has been adapted for use
on the Romanian population [38].
The BDI-II [24,29], a 21-item version of the original BDI
[39], is one of the most widely used self-report measures of
depression. Participants rate the intensity of depressive
symptoms on a Likert scale from 0 to 3, where 0 corre-
sponds to lack of the symptom, while 3 corresponds to the
highest intensity. The psychometric properties of the ori-
ginal BDI are well established, and the BDI-II also appears
to be psychometrically strong [24]. The BDI-II has been
adapted for use with the Romanian population [40], and
has adequate psychometric properties [41].
Measures of secondary outcomes
The Social Adjustment Scale (SAS) [42-44] is a self-report
measure of social functioning used in both research and
clinical practice. The questions are designed to assess six
key role areas: 1) work, 2) social and leisure activities, 3) re-
lationships with extended family, 4) role as a marital part-
ner, 5) parental role, and 6) role within the family unit. The
items are coded on a five-point Likert scale. An overall
score is obtained, as well as scores for each of the six role
areas [45]. Larger scores denote greater impairment. The
SAS has been translated into Romanian and adapted for
the purposes of this study, as described further below.
The World Health Organization Quality of Life BREF
(WHOQOL-BREF; [46]) is a 26-item self-report tapping
into the following broad domains: physical health, psy-
chological health, social relationships, and environment.
The Cronbach’s α values for these domains are accept-
able, varying from .68 to .81 [47-49]. Items are rated on
a five-point Likert scale and scored in a positive direction
(that is, higher scores indicate higher quality of life). The
scale has been translated and adapted into Romanian for
the purposes of the current study.
Measures of other outcomes
For the first set of additional outcomes used in this
study, the following measures are used.
 The FES is a scale adapted and expanded by the
authors from the High-K Strategy Scale (HKSS)
[50]. The HKSS has been shown to be negatively
associated with depressive symptomatology [25] and
psychopathology in general [23]. The FES consists of
45 items (58 if the patient has children), tapping into
various dimensions theorized to make up the indicators
of fitness. Participants rate every item on a five-point
Likert scale. A total FES score is computed by adding
up ratings for each item, with higher scores indicating
greater fitness. The FES was preliminarily validated
on a sample of 146 subjects, and showed good
internal consistency (Cronbach’s α = 0.93). The
FES is the therapist’s starting point in prescribing
the evolutionary-driven interventions, as further
detailed below.
 The Mate Value Inventory (MVI) [26] is a
multivariate assessment of attributes desired in the
self, and in social or sexual partners.The MVI is a
list of 17 traits, for which participants are asked,
‘How well do you feel that these attributes apply to
you currently,’ and are measured on a scale of −3
(extremely low on this trait) to +3 (extremely high
on this trait). These traits are: ambitious, attractive
face, attractive body, desires children, emotionally
stable, enthusiastic about sex, faithful to partner,
financially secure, generous, good sense of humor,
healthy, independent, intelligent, kind and
understanding, loyal, responsible, and sociable. Mate
value is the summed score of these items. The MVI
has been translated and adapted into Romanian for
the purposes of the current study.
 The Components of Mate Value Survey (CMVS)
[51] is a 21-item self-report measure. It is based on
the Self-Perceived Mating Success Scale (SPMSS)
[52], but in addition to the aspects of mate value
indexed by SPMSS, it includes aspects related to
sociality, parenting, wealth, looks, relationships
history, and fear of failure. The CMVS has
adequate reliability [26], and has been adapted into
Romanian for the purposes of this study.
 Behavioral Inhibition System/Behavioral Activation
System (BIS/BAS) [53] is a 20-item self-report
questionnaire that consists of a Behavioral Inhibition
subscale (making up the BIS) and three Behavioral
Activation subscales (making up the BAS). Each
item is rated on a four-point Likert scale, from 1
(strongly agree) to 4 (strongly disagree). A number
of studies have indicated adequate psychometric
properties [54,55]. The BIS/BAS scales have been
validated on the Romanian population in previous
studies [55].
 The Physical Health Questionnaire (PHQ) [56] is a
brief 14-item self-report scale used to assess frequency
of somatic symptoms (gastrointestinal problems,
headaches, sleep disturbances, and respiratory
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problems). Items 1–11 are rated on a seven-point
frequency scale, ranging from 1 (not at all) to 7
(all of the time). Items 12–14 have different
frequency-related responses, but the participant
uses the same seven-point frequency scale. Higher
mean scores reflect better somatic health. The
PHQ has shown good psychometric properties
[57-60], and has been translated into Romanian for
the purposes of this study.
 The Santa Clara Strength of Religious Faith
Questionnaire (SCSRFQ) is a brief, reliable and valid
self-report measure assessing strength of religious
faith and engagement, which is suitable for use with
multiple religious traditions. It comprises 10 items,
scored on a four-point Likert scale, with higher
scores denoting increased levels of religious faith.
The SCSRFQ has been widely used in medical,
student, psychiatric, and general populations
internationally, and has good psychometric
properties [61-65]. The questionnaire has been
translated and adapted into Romanian for the
purposes of this study.
 Brief COPE (B-COPE) [66] is a 28-item brief form
of a previously published measure called the COPE
inventory [67], which has proven to be useful in
health-related research. Respondents rate the items
on a four-point Likert scale, from 1 (I haven’t been
doing this at all) to 4 (I’ve been doing this a lot).
Scores are derived separately for two main categories
of coping strategies, namely, ‘emotion focused’ and
‘problem focused’ coping. B-COPE has been
successfully used on Romanian samples [40].
 The Positive and Negative Affect Scale (PANAS)
[68] is a 20-item self-report questionnaire, designed
to assess mood. It distinguishes between positive and
negative affect. Participants rate each item on a
five-point Likert scale, from 1 (very slightly/not at all)
to 5 (extremely) to indicate how they felt during the
indicated timeframe. The PANAS can be used to
assess mood on various time scales by altering the
instructions. Possible time scales include moment,
today, past few days, past week, past few weeks, past
year, and general. For the purposes of this study, we
used a 2-week interval. The validity and internal
consistency of the PANAS are good, with test–retest
reliability being the highest for the ‘general’ temporal
instruction [68]. The PANAS has been used
previously on the Romanian population, and was found
to have adequate psychometric properties [69,70].
To explore the different mechanisms by which the two
treatment approaches (ED-CT and CT) might lead to im-
provement (that is, the second set of additional outcomes),
the following measures are administered.
 The Automatic Thoughts Questionnaire (ATQ) [71]
is a 15-item self-report measure used to assess
depression-related cognitions. Participants rate on a
five-point scale, (from 1 (never) to 5 (almost all the
time)) how frequently they have had a given thought
over the past week. A higher score shows a higher
frequency of automatic thoughts. The psychometric
properties of the ATQ have been adequately demon-
strated in previous studies [72].
 The Dysfunctional Attitudes Scale (DAS) [73] is a
40-item self-report instrument which measures atti-
tudes that, according to the cognitive theory of de-
pression, contribute to vulnerability for depression.
Participants rate on a seven-point scale, from 7
(total disagreement) to 1 (total agreement), the level
of personal concordance with the item presented.
The higher the score, the more dysfunctional the
participant’s attitudes. Adequate internal consistency
and test-retest reliability for DAS have been reported
in the literature [74].
 The General Attitudes and Beliefs Scale (GABS) [75]
is a 26-item self-report instrument that measures ir-
rational beliefs related to six different content areas:
achievement, approval, comfort, justice, self, and
others. In addition, the scale includes a short index
of rational beliefs. Participants rate on a five-point
scale the level of agreement or disagreement with
the item presented, from 1 (strongly disagree) to 5
(strongly agree). Adequate psychometric properties
have been reported in the literature [75,76].
 The Attitude and Beliefs Scale II (ABS II) [76] is a
72-item instrument that measures irrational cognitions
(that is, demandingness, global evaluation/self-downing,
low frustration tolerance, and awfulizing) shown to be
involved in the onset and maintenance of emotional
distress, as well as their rational counterparts
(preferential thinking, unconditional self-acceptance,
frustration tolerance, and non-awfulizing). Each item
is rated on a five-point Likert scale, from 0 (strongly
disagree) to 4 (strongly agree). A total irrationality
score is obtained by summing up the scores on each
irrationally worded item, and the reverse scored
responses on each rationally worded item. Higher
scores indicate a higher level of irrationality.
All the instruments in the second set of additional
outcomes have been successfully used previously with
the Romanian population (ATQ [77-79]; DAS [78-80];
GABS [77-79]; ABS II [81-83]).
The third set of additional outcomes contains the
following measures.
 The Working Alliance Inventory (WAI) [84,85] is a
12-item self-report global measure of the therapeutic
Giosan et al. Trials 2014, 15:83 Page 6 of 12
http://www.trialsjournal.com/content/15/1/83
alliance. The WAI has three subscales: 1) emotional
bond of trust and rapport between the counselor
and client, 2) agreement about the overall goals of
treatment, and 3) agreement about the tasks relevant
for achieving these goals. Items are rated on a
seven-point Likert scale and the scale has shown
good internal consistency, as well as good construct,
concurrent, and predictive validity [85-87]. The
questionnaire has been translated and adapted into
Romanian for the purposes of this study.
 Treatment outcome expectancies are measured
using 10-cm visual analogue scales (VASs). This
approach has shown good reliability in multiple
studies [88,89]. Treatment outcome expectancies are
measured at intake and at mid-treatment.
 The intent to attend the next session is also assessed
using the Intent-to-Attend Scale [90], a single-item
measure. Participants rate their intention on a
nine-point Likert scale.
 After each therapy session, participants’ satisfaction
with the treatment is evaluated using the Client
Satisfaction Questionnaire [91-93], the eight-item
version. The CSQ-8 assesses global patient satisfaction
with a four-point Likert, scale and also provides a
general score varying from 8 to 32. This questionnaire
has been translated and adapted into Romanian for
the purposes of this study.
All the instruments adapted into Romanian for the pur-
poses of the present study were independently translated by
two Romanian English-proficient PhD-level clinical psychol-
ogists with good knowledge of the constructs measured.
Disagreements were resolved through discussions between
the translators, and two Romanian senior clinical psycholo-
gists also reviewed and approved the final versions.
Participant timeline
For the study, potential participants are provided with
verbal and written information during the first appointment
with a clinical psychologist. Written consent for the
participation in the clinical evaluation part of the study
is sought at this time. A second appointment is sched-
uled, in which the respondents are evaluated clinically.
If the inclusion criteria are met, written consent for
participation in the treatment part of the study is obtained,
within a 2-week interval.
The participants are then randomized by a research
assistant to receive either: 1) ED-CT or 2) CT, without
being informed about their group allocation (see flowchart
in Figure 1). Randomization is performed a priori using
a computer software package (www.randomizer.org). In
addition, the clinical psychologists who perform the clin-
ical assessment are blinded to the experimental condition
through the entire duration of the study. Participants who
do not meet the criteria for the study are referred to the
Babes-Bolyai Psychological Clinic or to a psychiatric clinic
in Cluj-Napoca.
Sample size
An a priori power analysis based on a medium effect
size estimation indicated that a total of 100 participants
are needed (planned main statistical test is ANOVA
(repeated measures, between factors); f effect size: 0.247;
statistical power: 0.80; α error probability: 0.05; two groups,
two main measurements (pre-intervention and post-
intervention); correlation between repeated measures: .50).
Power analysis was computed using the G*Power 3.1.6
program [95]. Consequently, we randomized a total of 100
participants. Following generation of the random num-
bers, we decided to use the first sequence of numbers for
the participants’ allocation to the groups. This resulted
in 43 participants randomized to the CT group, and 57
participants randomized to the ED-CT group.
Recruitment
An initial telephone interview screens out those people
whose participation in the study is motivated by prob-
lems other than their mood. The potential subjects then
undergo a clinical evaluation, performed by doctoral-
level clinical psychologists certified by the Romanian
Board of Psychologists, and currently supervised in their
activity by senior psychologists. They have been trained
in using the SCID [37] as part of their clinical program, at
Babes-Bolyai University. Additionally, for the purposes of
this study, all of them received specific practical training
in administering the SCID modules used in the current
protocol. To ensure the adequacy of the assessment pro-
cedure, all the initial clinical evaluations are audio recorded
and randomly verified by a senior clinical psychologist.
Moreover, all the potential eligible cases are discussed with
the same senior clinical psychologist before enrolment.
Every evaluation is audio recorded, to allow for reli-
ability checks for depression diagnoses, performed by
an independent evaluator, on 25% of randomly selected
interviews. SCID [37] and BDI-II [24,29] (see above) are
used for purposes of evaluating eligibility.
Prospective participants are recruited into the treat-
ment study by clinical psychologists at the Babes-Bolyai
University Psychological Clinic. Potential participants
are also referred by psychiatric clinics that collaborate
with Babes-Bolyai University as well as by private practices.
Additionally, media avenues (for example, local newspapers,
radio, social networks) as well as posters and fliers are used
for recruitment purposes.
Assignment to interventions
The participants are randomly assigned to one of the
two conditions using a sequence generated by the software
Giosan et al. Trials 2014, 15:83 Page 7 of 12
http://www.trialsjournal.com/content/15/1/83
Randomizer.org. Randomization is performed by a research
assistant using a simple (unrestricted) randomization
sequence that assigns two unique numbers per partici-
pant; the number assigned is either 1 or 2, according to
the number of experimental conditions. To conceal the
allocation mechanism, the same research assistant puts
the patient in touch with their therapist without revealing
anything about the intervention protocol to be imple-
mented by that therapist.
The CT and ED-CT therapy protocols are each delivered
by two different psychotherapists. All four psychotherapists
are certified by the Romanian Board of Psychologists,
and have extensive training in CT, completed through
the Romanian Association of Cognitive and Behavioral
Psychotherapies. The two psychotherapists delivering
the ED-CT protocol have received additional training
in the evolutionary components of the ED-CT protocol.
Under the direct supervision of the principal investigator,
the therapists have undergone 6 weeks of training, follow-
ing the protocol manual for the ED-CT group.
The principal investigator and the statisticians running
the data analysis will remain blinded to the experimental
condition until the completion of the study.
Data collection, management, and analysis
Each eligible patient is assigned a unique identification
number and asked to complete the evaluation package,
including the primary, secondary, and other outcomes,
as well as demographic information (initial assessment).
The same set of measures is administered after the final
session (post-intervention assessment) and at 3 months
after the final session (follow-up assessment). After ses-
sions 4 and 8, patients also complete several measures of
primary outcomes (that is, BDI-II), and other outcomes
(ATQ, DAS, ABS II, PANAS, B-COPE, treatment outcome
expectancies,WAI, CSQ-8, and Intent-to-Attend Scale).
In addition, the participants complete the BDI-II, CSQ-8,
and Intent-to-Attend Scale after each session.
To ensure high accuracy of data collection, all the mea-
sures are completed electronically, via a special system de-
signed to reliably capture and organize the data points
while minimizing the risk of missing responses. The system
has been especially developed for the purposes of this study,
and is secured on a server. Each participant uses their
unique identification number to log on to the system. The
therapists are responsible for assisting the patients in this
process, and providing clarifications when needed.
Referred to study
Assessed for eligibility (telephone screening and clinical interview)
Information sheet and consent form
RANDOMIZATION (N=100)
Pre-treatment questionnaires
COGNITIVE 
THERAPY
N=43
EVOLUTIONARY 
DRIVEN
COGNITIVE 
THERAPY N=57
Every session questionnaires (12 sessions)
Mid-treatment questionnaires (session 4 and 8)
Post-treatment questionnaires Post-treatment questionnaires
Follow-up questionnaires
3-months post-treatment
Follow-up questionnaires
3-months post-treatment
Figure 1 CONSORT flow diagram [94] showing subject allocation to the therapy conditions.
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To promote participant retention and follow-up com-
pletion, several strategies are being used. First, the par-
ticipants receive a clear and complete description about
the project, including, but not limited to, information re-
garding the type of psychotherapy offered, that is, CT,
which is the standard of care in the psychological treat-
ment for depression, having remission rates comparable
with medication, and being more efficient than medica-
tion alone in the long term. The participants are also
informed that the treatment is being provided free by
therapists trained in the top-ranked Department of Clinical
Psychology and Psychotherapy in the country [96], recently
added, through its academic spin-off, the International
Institute for the Advanced Studies of Psychotherapy and
Applied Mental Health, to the Mapping of the European
Research Infrastructure Landscape (MERIL) network [97].
Because in Romania psychotherapy sessions are not reim-
bursed by health insurance companies, we expect that this
financial factor will also act as a motivator for the patient
to stay in treatment. Furthermore, the therapy sessions are
scheduled in a flexible manner, according to the patient’s
preferences. Additionally, the therapist will call the partici-
pant the day before the planned session for a brief check,
and to ensure continuation in therapy. Most importantly,
to ensure retention, at the end of each session the partici-
pants complete the ‘Intend-to-Attend’ one-item scale,
which is meant to promote commitment to the thera-
peutic process as well as to detect any issues that might
require the therapist’s special attention. Lastly, the thera-
pists carefully prepare the end session of the therapy and
explain to the participants that they will keep in touch.
The therapists also remind the patients at this time
that the free treatment was possible because of a re-
search grant, which makes the collection of follow-up
measurements essential.
The severity of, and improvement in the BDI-II scores
within and between the groups will be examined using
mixed-effects linear regression analysis with a random
intercept and slope over time (four assessments: baseline,
after sessions 4 and 8, post-treatment) and fixed effects for
treatment assignment.) The 3-month follow-up data will
be analyzed in a separate mixed-effects model. The main
analysis will compare groups in terms of depression level
(that is, diagnostic status and symptom intensity). Results
on the other measures will be investigated in an exploratory
manner. When analysis of secondary/other outcomes are
performed, the error probability will be adjusted according
to the number of group comparisons performed [98].
Monitoring study implementation
The management of unintended effects or harm (that is,
clinically significant increase in depressive symptomatology,
as measured by the BDI-II), is performed by the supervising
clinical psychologist employed for this study, who monitors
the clinical evaluations and therapy sessions. If neces-
sary, the supervisor can decide to terminate the treatment/
clinical assessment and make a further referral.
Ethics and dissemination
The study has been approved by the ethics commission
at Babes-Bolyai University. As with any study on depres-
sion, there are ethical concerns that need to be addressed.
First, the exclusionary criteria exclude people who pose an
imminent danger to themselves or others. These people
will be immediately referred to the appropriate services
dealing with such cases. Second, if a patient’s condition
worsens during the therapy, the supervising clinical psych-
ologist can opt to terminate the treatment ahead of sched-
ule and make an appropriate referral. Third, people with
mental conditions other than depression are also ex-
cluded, and will be referred to the services best suited to
dealing with their problems.
One arm of this clinical trial involves interventions
that stem from an evolutionary understanding of human
behavior. The role of the SCSRFQ scale, administered at
intake, is to assess the strength of religious beliefs before
the first session, when the ED-CT conceptualization takes
place. Special care will be taken with the patients whose re-
ligious beliefs might make them less receptive to the theor-
etical framework of such interventions. In such cases, the
therapist will be mindful of the patient’s beliefs, and explain
the basic tenets of ED-CT in a very sensitive manner.
Finally, confidentiality and privacy are of paramount
importance. The completed forms of the clinical instru-
ments are kept in locked cabinets and the access to the
electronic data is password-protected. The passwords are
changed regularly, and the clinical assessment reports
contain no identifying information.
Dissemination policy
The principal investigator and the research team intend
to publish the trial results in a peer-reviewed journal,
focusing on two main areas: 1) primary outcomes results
and 2) mechanisms of change results. Presentations at
international conferences on the topic are also envi-
sioned. Furthermore, the intervention manual will be
sent out for publication, and will be made available upon
request from the first author.
Discussion
This protocol describes a randomized trial comparing
two interventions for depression: classic CT and the newly
proposed ED-CT. As the costs of depression continue to
mount [99], it is imperative that new approaches be tested
and validated, and if successful, implemented. Given the
high prevalence of depression and its projected costs, even
incremental benefits of novel approaches can translate
into billions of dollars in savings.
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To our knowledge, this is the first attempt to integrate
insights from evolutionary theories of depression into
the treatment of this condition in a controlled manner. This
study can thus add substantially to the body of knowledge
on validated treatments for depression. The randomized
controlled design is rigorous, allowing the authors to arrive
at valid conclusions about the comparative efficiency of
these two interventions at the end of the study.
There are, nonetheless, several caveats that must be
acknowledged. As with any clinical trial testing psycho-
therapeutic interventions, therapist blinding is not possible.
To minimize possible biases, the principal investigator will
not be involved in any therapeutic sessions. In addition,
because of the ethical concerns of keeping patients with
depression on a waiting list for 12 weeks, the present
study lacks a control group in that sense.
This randomized trial is a first step in the development
of an evolutionary-driven intervention for depression. If
the treatment is shown to be at least comparable with CT,
then a future trial will examine whether this intervention
is associated with lower relapse or other longer-term out-
comes such as improved health.
Trial status
Participant recruitment began on September 1, 2012.
Randomization of the participants was performed on
September 27, 2012. The first participant was enrolled
on October 3, 2012.
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